ConvaTec Group PLC banner

ConvaTec Group PLC
LSE:CTEC

Watchlist Manager
ConvaTec Group PLC Logo
ConvaTec Group PLC
LSE:CTEC
Watchlist
Price: 230 GBX -1.71% Market Closed
Market Cap: £4.5B

ConvaTec Group PLC
EPS (Diluted)

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

ConvaTec Group PLC
EPS (Diluted) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company EPS (Diluted) CAGR 3Y CAGR 5Y CAGR 10Y
ConvaTec Group PLC
LSE:CTEC
EPS (Diluted)
$0
CAGR 3-Years
44%
CAGR 5-Years
8%
CAGR 10-Years
N/A
Abingdon Health PLC
LSE:ABDX
EPS (Diluted)
£0
CAGR 3-Years
51%
CAGR 5-Years
13%
CAGR 10-Years
N/A
Tristel PLC
LSE:TSTL
EPS (Diluted)
£0
CAGR 3-Years
32%
CAGR 5-Years
10%
CAGR 10-Years
18%
Inspecs Group PLC
LSE:SPEC
EPS (Diluted)
£0
CAGR 3-Years
0%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Advanced Medical Solutions Group PLC
LSE:AMS
EPS (Diluted)
£0
CAGR 3-Years
-18%
CAGR 5-Years
5%
CAGR 10-Years
-3%
Rua Life Sciences PLC
LSE:RUA
EPS (Diluted)
£0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

ConvaTec Group PLC
Glance View

Market Cap
4.5B GBX
Industry
Health Care

ConvaTec Group PLC is a notable player in the realm of medical products and technologies, deftly weaving its narrative within the healthcare industry. Founded in 1978, the company has steadily established itself through strategic expansion and innovation, focusing on improving the lives of patients and enhancing healthcare delivery. The company's core business revolves around four main product categories: Advanced Wound Care, Ostomy Care, Continence and Critical Care, and Infusion Care. Each of these sectors is backed by a robust commitment to research and development, allowing ConvaTec to deliver specialized products that cater to both specific patient needs and broader healthcare system demands. ConvaTec's financial model centers around providing essential, high-quality medical solutions that ultimately support improved patient outcomes. The company garners revenue by partnering with hospitals, healthcare providers, and direct consumer channels, ensuring its products reach where they are most needed. With a global footprint spanning multiple continents, ConvaTec not only distributes its products widely but also adapts its strategy to meet the nuanced requirements of diverse markets. By aligning itself closely with caregivers and leveraging cutting-edge technology, the company maintains a sustainable economic engine through both recurring sales from consumables and long-term relationships with its institutional clients.

CTEC Intrinsic Value
200.95 GBX
Overvaluation 13%
Intrinsic Value
Price GBX230

See Also

What is ConvaTec Group PLC's EPS (Diluted)?
EPS (Diluted)
0.1 USD

Based on the financial report for Dec 31, 2025, ConvaTec Group PLC's EPS (Diluted) amounts to 0.1 USD.

What is ConvaTec Group PLC's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 5Y
8%

Over the last year, the EPS (Diluted) growth was 0%. The average annual EPS (Diluted) growth rates for ConvaTec Group PLC have been 44% over the past three years , 8% over the past five years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett